{"filing":{"accession_number":"0001127537-26-000035","cik":"0001127537","ticker":"LUNG","company_name":"Pulmonx Corp","form":"8-K","filing_date":"2026-07-29","report_date":"2026-07-29","primary_document":"lung-20260729.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1127537/000112753726000035/lung-20260729.htm"},"events":[{"id":21610,"run_id":19494,"accession_number":"0001127537-26-000035","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"Pulmonx issued a press release on July 29, 2026, announcing its financial results for the second quarter ended June 30, 2026. The disclosure includes detailed quarterly revenue ($22.8 million), gross margin (78%), net loss ($10.1 million or $0.24 per share), and full-year 2026 guidance ($90–$92 million revenue, ~76% gross margin). This is a standard earnings release disclosure under Item 2.02, material to investors assessing the company's operational and financial performance.","company_name":"Pulmonx Corp","ticker":"LUNG","filing_date":"2026-07-29","form":"8-K","submitted_at":null,"items":[{"id":21293,"accession_number":"0001127537-26-000035","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Pulmonx issued a press release on July 29, 2026, announcing its financial results for the second quarter ended June 30, 2026. The disclosure includes detailed quarterly revenue ($22.8 million), gross margin (78%), net loss ($10.1 million or $0.24 per share), and full-year 2026 guidance ($90–$92 million revenue, ~76% gross margin). This is a standard earnings release disclosure under Item 2.02, material to investors assessing the company's operational and financial performance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-29T20:12:32.764716+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":21293,"accession_number":"0001127537-26-000035","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Pulmonx issued a press release on July 29, 2026, announcing its financial results for the second quarter ended June 30, 2026. The disclosure includes detailed quarterly revenue ($22.8 million), gross margin (78%), net loss ($10.1 million or $0.24 per share), and full-year 2026 guidance ($90–$92 million revenue, ~76% gross margin). This is a standard earnings release disclosure under Item 2.02, material to investors assessing the company's operational and financial performance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-29T20:12:32.764716+00:00","company_name":"Pulmonx Corp","ticker":"LUNG","filing_date":"2026-07-29"}]}